Showing results (161-170 of 389) with videos related to

Sort By:
Pageof 39
Endocrine-Related Cancer|January 17, 2019
MDR1 inhibition increases sensitivity to doxorubicin and etoposide in adrenocortical cancerS G Creemers, P M van Koetsveld, W W De Herder, et al.
World Journal of Surgery|July 5, 2002
Safe retroperitoneal endoscopic resection of pheochromocytomasFrits J Berends, Erwin Van Der Harst, Giuseppe Giraudo, et al.
European Journal of Endocrinology|December 1, 2011
Serum inhibin pro-αC is a tumor marker for adrenocortical carcinomasJohannes Hofland, Richard A Feelders, Ronald van der Wal, et al.
The Journal of Clinical Endocrinology and Metabolism|January 9, 2022
Sexual Dimorphism in Small-intestinal Neuroendocrine Tumors: Lower Prevalence of Mesenteric Disease in Premenopausal WomenAnela Blažević, Anand M Iyer, Marie-Louise F van Velthuysen, et al.
European Journal of Endocrinology|August 3, 2002
Sequential ACTH and catecholamine secretion in a phaeochromocytomaP Sytze van Dam, Ad van Gils, Marijke R Canninga-van Dijk, et al.
Endocrine-Related Cancer|July 23, 2020
Critical appraisal of MGMT in digestive NET treated with alkylating agentsLouis de Mestier, Anne Couvelard, Anela Blazevic, et al.
The Journal of Clinical Endocrinology and Metabolism|December 20, 2018
Symptomatic and Radiological Response to 177Lu-DOTATATE for the Treatment of Functioning Pancreatic Neuroendocrine TumorsWouter T Zandee, Tessa Brabander, Anela Blažević, et al.
European Journal of Endocrinology|August 3, 2002
Central ghrelin production does not substantially contribute to systemic ghrelin concentrations: a study in two subjects with active acromegalyFanny M van der Toorn, Joop A M J L Janssen, Wouter W de Herder, et al.
European Journal of Endocrinology|January 15, 2009
Combined treatment for acromegaly with long-acting somatostatin analogs and pegvisomant: long-term safety for up to 4.5 years (median 2.2 years) of follow-up in 86 patientsS J C M M Neggers, W W de Herder, J A M J L Janssen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 6, 2012
Lutetium-labelled peptides for therapy of neuroendocrine tumoursB L R Kam, J J M Teunissen, E P Krenning, et al.
Pageof 39